rs11982486

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000305.3(PON2):​c.75-1701A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.29 in 152,078 control chromosomes in the GnomAD database, including 6,868 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.29 ( 6868 hom., cov: 32)

Consequence

PON2
NM_000305.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.28

Publications

6 publications found
Variant links:
Genes affected
PON2 (HGNC:9205): (paraoxonase 2) This gene encodes a member of the paraoxonase gene family, which includes three known members located adjacent to each other on the long arm of chromosome 7. The encoded protein is ubiquitously expressed in human tissues, membrane-bound, and may act as a cellular antioxidant, protecting cells from oxidative stress. Hydrolytic activity against acylhomoserine lactones, important bacterial quorum-sensing mediators, suggests the encoded protein may also play a role in defense responses to pathogenic bacteria. Mutations in this gene may be associated with vascular disease and a number of quantitative phenotypes related to diabetes. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
PON2 Gene-Disease associations (from GenCC):
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000305.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.343 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000305.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PON2
NM_000305.3
MANE Select
c.75-1701A>G
intron
N/ANP_000296.2Q15165-2
PON2
NM_001018161.2
c.75-1701A>G
intron
N/ANP_001018171.1Q15165-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PON2
ENST00000222572.8
TSL:1 MANE Select
c.75-1701A>G
intron
N/AENSP00000222572.3Q15165-2
PON2
ENST00000633192.1
TSL:1
c.138-1701A>G
intron
N/AENSP00000488378.1A0A0J9YXF2
PON2
ENST00000633531.1
TSL:1
c.75-1701A>G
intron
N/AENSP00000488838.1Q15165-2

Frequencies

GnomAD3 genomes
AF:
0.290
AC:
44131
AN:
151960
Hom.:
6868
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.279
Gnomad AMI
AF:
0.262
Gnomad AMR
AF:
0.217
Gnomad ASJ
AF:
0.368
Gnomad EAS
AF:
0.00519
Gnomad SAS
AF:
0.218
Gnomad FIN
AF:
0.227
Gnomad MID
AF:
0.299
Gnomad NFE
AF:
0.347
Gnomad OTH
AF:
0.296
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.290
AC:
44146
AN:
152078
Hom.:
6868
Cov.:
32
AF XY:
0.278
AC XY:
20679
AN XY:
74352
show subpopulations
African (AFR)
AF:
0.279
AC:
11572
AN:
41480
American (AMR)
AF:
0.216
AC:
3305
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.368
AC:
1276
AN:
3470
East Asian (EAS)
AF:
0.00521
AC:
27
AN:
5186
South Asian (SAS)
AF:
0.219
AC:
1054
AN:
4816
European-Finnish (FIN)
AF:
0.227
AC:
2397
AN:
10572
Middle Eastern (MID)
AF:
0.305
AC:
89
AN:
292
European-Non Finnish (NFE)
AF:
0.347
AC:
23568
AN:
67970
Other (OTH)
AF:
0.294
AC:
619
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1584
3168
4753
6337
7921
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
454
908
1362
1816
2270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.326
Hom.:
10450
Bravo
AF:
0.285
Asia WGS
AF:
0.111
AC:
390
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
0.14
DANN
Benign
0.61
PhyloP100
-2.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs11982486;
hg19: chr7-95055598;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.